Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Blood Donation Study for ALPCO Syphilis-T and Syphilis-NT Assay Development

NCT: NCT07830550 · ENROLLING_BY_INVITATION

NCT IDNCT07830550
StatusENROLLING_BY_INVITATION
Start Date2026-10
Completion2026-12
SponsorAmerican Laboratory Products Company (INDUSTRY)
First posted
Last updated

Brief Summary

This prospective, single-center study will collect blood from approximately 50 adult volunteers aged 22 years or older. Participants will provide informed consent, complete an eligibility review, and undergo one blood draw of approximately 20-50 mL. The blood will be processed into serum and labeled with a study identification number. The serum may be used to prepare laboratory samples with defined antibody levels to support the development and performance evaluation of the ALPCO Syphilis-T and Syphilis-NT assays. All testing is for research purposes only. Individual test results will not be provided to participants or used for diagnosis or treatment.

Frequently Asked Questions

What is Blood Donation Study for ALPCO Syphilis-T and Syphilis-NT Assay Development?

Blood Donation Study for ALPCO Syphilis-T and Syphilis-NT Assay Development is a clinical trial registered under NCT07830550. Current status: ENROLLING_BY_INVITATION.

What is the status of NCT07830550?

The current status of NCT07830550 (Blood Donation Study for ALPCO Syphilis-T and Syphilis-NT Assay Development) is: ENROLLING_BY_INVITATION.

When did Blood Donation Study for ALPCO Syphilis-T and Syphilis-NT Assay Development start?

Blood Donation Study for ALPCO Syphilis-T and Syphilis-NT Assay Development started on 2026-10.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.